Join to access to all OVN content. Join for Free
The Great Resignation is Now The Great Hesitation
careers

The Great Resignation is Now The Great Hesitation


Share This Article


Over the last few years, the employment market has moved through dramatic swings. In 2021 and 2022, millions of professionals left their roles in what became known as The Great Resignation. Jobs were abundant, companies were aggressively hiring, and the perceived level of risk was low. If a new role did not work out, another company seemed ready with a similar or better offer. That season inspired fast movement because it felt safe to leap, reset, and repeat if needed.

Today a different pattern has emerged. People are still thinking about career change, but the pace has slowed. I call this shift The Great Hesitation. It is not fueled by complacency or lack of ambition. It is fueled by calculation. The career landscape feels more like the quiet middle game of a chess match than a free spin at a prize wheel. Professionals know that a wrong move can be costly, not just inconvenient. With fewer open roles, stricter hiring requirements, and more competition for each seat, there is less margin for error.

This caution is shaped by several forces. Headlines continue to highlight inflation, layoffs, funding pressure, consolidation, and reorganizations. Many fear being the newest hire during uncertain seasons. Memories of rapid exits during The Great Resignation, followed by disappointment or misalignment, have also left a lasting impression. Some of those moves worked beautifully, but others revealed that not e very green pasture stays green. That experience turned curiosity into due diligence.

Remote and hybrid flexibility has become valuable and is now something people are reluctant to surrender, especially as many companies increase their in-office expectations. When a current role offers stability, familiarity, and flexibility, it becomes harder to roll the dice on an unknown environment. The result is a long pause, similar to when a chess player studies the board with full awareness that a single move can influence the rest of the game.

From a distance, this may resemble Job Hugging, but the motivations differ. Job Hugging is rooted in fear and comfort, similar to gripping the edge of the board because movement feels dangerous. The Great Hesitation is rooted in selectivity. It is not freezing. It is filtering.

This shift also changes how hiring leaders must operate. Salary and job titles no longer close the deal. Top candidates want evidence that they are stepping into a stable environment with people they can trust. Hiring managers must sell stability and culture the same way candidates have always been expected to sell their value.

That means defining what success looks like, sharing how decisions are made, showing how the team operates, and giving real examples of consistency and leadership strength. When candidates can picture themselves succeeding, hesitation turns into engagement. Candidates also carry responsibility. A thoughtful pause is wise, but permanent stillness can limit growth.

The healthiest strategy is to define what matters most, assess leadership as carefully as role scope, and treat career change as a long-term investment rather than an escape or a title upgrade. The wrong move can cost momentum, but the right move can change the entire board.

The Great Resignation chased possibility. The Great Hesitation weighs probability.

The future belongs to candidates who can tell the difference and the managers who can sell the difference.

Michael Pietrack

Was this helpful?  Information like this can be routinely found on The Pharmaverse Podcast.

About the Author: Michael Pietrack leads the power-packed Life Sciences Recruiting team at Kaye/Bassman International (www.KBICLifeSciences.com). With nearly 20 years of high performance, Pietrack is the go-to recruiter in Medical Affairs. Additionally, he is a trusted voice on leadership. He hosts a leadership podcast called The Pharmaverse and writes a column for BioSpace called Leadership Lab.

Click for Source

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
3 Things I wish I knew about being a MSL
Partner Avatar MSL Talk: Tom Caravela, Mitchell D’Rozario

3 Things I wish I knew about being a MSL

Article
Leadership Lab: How To Spot When Employees Are About To Walk Away
Partner Avatar Michael Pietrack

Leadership Lab: How To Spot When Employees Are About To Walk Away

Article
How to Know When to Make a Job Change
Partner Avatar Michael Pietrack

How to Know When to Make a Job Change

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Explore OVN